3128-85-6Relevant articles and documents
INHIBITOR OF APOPTOSIS (IAP) PROTEIN ANTAGONISTS
-
Paragraph 00238-00239, (2021/11/06)
Provided herein are compounds that modulate the activity of melanoma inhibitor of apoptosis (ML-IAP) protein, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
Divergent synthesis of isonitriles and nitriles by palladium- catalyzed benzylic substitution with TMSCN
Hirano, Koji,Miura, Masahiro,Asai, Kento
, p. 12703 - 12714 (2020/11/09)
Ligand-controlled palladium-catalyzed divergent synthesis of isonitriles and nitriles from benzylic carbonates and TMSCN has been developed. The BINAP- or DPEphos-ligated palladium catalyst selectively provides the corresponding benzylic isonitriles, wher
USE OF INHIBITOR OF APOPTOSIS PROTEIN (IAP) ANTAGONISTS IN HIV THERAPY
-
Paragraph 00507, (2015/12/30)
Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV).